No inflammatory benefit obtained by single-incision laparoscopic surgery for right hemicolectomy compared with conventional laparoscopy.
Aged
Aged, 80 and over
Biomarkers
/ blood
Blood Loss, Surgical
/ statistics & numerical data
C-Reactive Protein
Colectomy
/ methods
Feasibility Studies
Female
Humans
Interleukin-6
/ blood
Laparoscopy
/ methods
Length of Stay
Male
Platelet Count
Postoperative Complications
/ diagnosis
Retrospective Studies
Systemic Inflammatory Response Syndrome
/ diagnosis
Vascular Endothelial Growth Factor A
/ blood
IL-6
Right hemicolectomy
SILS
Systemic inflammation
Journal
Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
29
10
2018
accepted:
20
01
2019
pubmed:
11
2
2019
medline:
18
12
2019
entrez:
11
2
2019
Statut:
ppublish
Résumé
We evaluated the perioperative inflammatory mediators in a right hemicolectomy performed with single-incision laparoscopic surgery (SILS) and traditional multi-port laparoscopic surgery (MLS) to compare the postoperative inflammatory response and feasibility of SILS with that of MLS. In this retrospective study, we enrolled 56 consecutive colorectal cancer patients who underwent right hemicolectomy prospectively. Twenty patients underwent SILS, and 36 underwent MLS. The preoperative and postoperative levels of plasma vascular endothelial growth factor (VEGF), serum interleukin-6 (IL-6), and C-reactive protein (CRP) as well as the number of platelet cells were measured in all patients. The operation duration, number of harvested lymph nodes, length of the resected bowel, blood loss, and duration of hospital stay were also compared between the two groups. Neither SILS nor MLS had any conversion cases. The operation duration was longer for MLS than for SILS. Blood loss tended to be lower among patients who underwent SILS than among those who underwent MLS. However, the number of harvested LNs was significantly lower with SILS than with MLS. In both pre- and postoperative blood examinations, there was no marked difference in inflammatory mediators between MLS and SILS. There was no systemic inflammatory advantage associated with SILS compared with MLS.
Identifiants
pubmed: 30739170
doi: 10.1007/s00595-019-01777-x
pii: 10.1007/s00595-019-01777-x
doi:
Substances chimiques
Biomarkers
0
Interleukin-6
0
Vascular Endothelial Growth Factor A
0
C-Reactive Protein
9007-41-4
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
621-628Références
J Laparoendosc Adv Surg Tech A. 1999 Aug;9(4):361-4
pubmed: 10488834
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Colorectal Dis. 2011 Apr;13(4):393-8
pubmed: 20002691
Surg Endosc. 2010 Oct;24(10):2613-6
pubmed: 20364353
Surg Endosc. 2011 Jun;25(6):1887-92
pubmed: 21359907
Endoscopy. 2011 Jun;43(6):526-32
pubmed: 21425040
Surg Innov. 2012 Jun;19(2):117-22
pubmed: 21914704
Surg Endosc. 2012 Mar;26(3):747-53
pubmed: 22002201
Surg Laparosc Endosc Percutan Tech. 2012 Feb;22(1):21-4
pubmed: 22318054
J Laparoendosc Adv Surg Tech A. 2012 Sep;22(7):621-4
pubmed: 22746163
Colorectal Dis. 2012 Nov;14(11):e764-70
pubmed: 22776288
Surg Endosc. 2013 Feb;27(2):471-7
pubmed: 22806522
Surg Endosc. 2013 Apr;27(4):1254-9
pubmed: 23232993
Surg Laparosc Endosc Percutan Tech. 2013 Aug;23(4):e164-7
pubmed: 23917608
Colorectal Dis. 2013;15(10):e618-22
pubmed: 23937552
Surg Endosc. 2014 Nov;28(11):3216-23
pubmed: 25027469
Ann Surg Treat Res. 2014 Sep;87(3):131-8
pubmed: 25247166
Br J Surg. 2015 May;102(6):630-7
pubmed: 25764376
J Invest Surg. 2015;28(6):341-5
pubmed: 26203723
Am J Surg. 2018 Aug;216(2):255-259
pubmed: 28683891
Dis Colon Rectum. 1994 Aug;37(8):754-9
pubmed: 8055718
Br J Surg. 1997 Mar;84(3):391-6
pubmed: 9117320
Br J Surg. 1997 May;84(5):695
pubmed: 9171771
Surg Endosc. 1998 Feb;12(2):177-8
pubmed: 9479738